298 related articles for article (PubMed ID: 2234176)
21. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
22. The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy.
Chellini E; Crocetti E; Carli P; Martini A; Giovannetti L
Melanoma Res; 2007 Apr; 17(2):129-30. PubMed ID: 17496788
[TBL] [Abstract][Full Text] [Related]
23. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
24. Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
Garbe C; Thiess S; Nürnberger F; Ehlers G; Albrecht G; Lindlar F; Bertz J
Acta Derm Venereol; 1991; 71(6):506-11. PubMed ID: 1685833
[TBL] [Abstract][Full Text] [Related]
25. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
26. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
[TBL] [Abstract][Full Text] [Related]
27. Malignant skin melanoma in Croatia.
Materljan E; Zamolo G; Petković M; Ivosević D; Popović B; Materljan M; Katunarić M; Jurisić D
Coll Antropol; 2009 Dec; 33(4):1363-8. PubMed ID: 20102094
[TBL] [Abstract][Full Text] [Related]
28. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
29. Sociodemographic factors and incidence of melanoma in the Netherlands, 1994-2005.
van der Aa MA; de Vries E; Hoekstra HJ; Coebergh JW; Siesling S
Eur J Cancer; 2011 May; 47(7):1056-60. PubMed ID: 21251812
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous malignant melanoma in Europe.
de Vries E; Coebergh JW
Eur J Cancer; 2004 Nov; 40(16):2355-66. PubMed ID: 15519506
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous malignant melanoma--clinical epidemiology and survival.
Nair MK; Varghese C; Mahadevan S; Cherian T; Joseph F
J Indian Med Assoc; 1998 Jan; 96(1):19-20, 28. PubMed ID: 9601186
[TBL] [Abstract][Full Text] [Related]
32. The control of melanoma in New Zealand.
Sneyd M; Cox B
N Z Med J; 2006 Sep; 119(1242):U2169. PubMed ID: 16998570
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of extracutaneous melanoma in the Netherlands.
Koomen ER; de Vries E; van Kempen LC; van Akkooi AC; Guchelaar HJ; Louwman MW; Nijsten T; Coebergh JW
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1453-9. PubMed ID: 20501769
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the mortality and incidence of cutaneous melanoma in Italy].
Maggini M; Petrelli G; Portoghesi F; Vollono C
Ann Ist Super Sanita; 1982; 18(3):591-4. PubMed ID: 7187848
[No Abstract] [Full Text] [Related]
35. [Prevention of cutaneous melanoma].
van der Rhee HJ; Coebergh JW
Ned Tijdschr Geneeskd; 1999 Jun; 143(26):1356-9. PubMed ID: 10416492
[TBL] [Abstract][Full Text] [Related]
36. [Cutaneous malignant melanomas in New Caledonia. Study of the Cancer Registry (1977-1987)].
Di Schino M; Merouze F; Huerre M; Grimaldi F; Lorthioir JM; Breda Y; Merrien Y
Med Trop (Mars); 1989; 49(3):271-6. PubMed ID: 2811654
[TBL] [Abstract][Full Text] [Related]
37. The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study.
Melia J; Moss S; Coleman D; Frost T; Graham-Brown R; Hunter JA; Marsden RA; du Vivier A; Warin AP; White J; Whitehead SM; Wroughton MA
Br J Cancer; 2001 Sep; 85(6):803-7. PubMed ID: 11556828
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological data on melanoma from the referral centre in croatia (2002-2007).
Buljan M; Rajacić N; Vurnek Zivković M; Blajić I; Kusić Z; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():47-51. PubMed ID: 19138006
[TBL] [Abstract][Full Text] [Related]
39. [Malignant melanoma: increase in incidence and mortality in West Germany].
Garbe C; Bertz J; Orfanos CE
Z Hautkr; 1986 Dec; 61(24):1751-64. PubMed ID: 3493596
[TBL] [Abstract][Full Text] [Related]
40. Are all melanomas dangerous?
Nørgaard C; Glud M; Gniadecki R
Acta Derm Venereol; 2011 Sep; 91(5):499-503. PubMed ID: 21874217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
